𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Androgen Receptor Expression in Prostatic Dysplasia (Prostatic lntraepithelial Neoplasia) in the Human Prostate: An Immunohistochemical and In Situ Hybridization Study

✍ Scribed by Dr. Irwin Leav; John E. McNeal; Paul W.-L. Kwan; Paul Komminoth; Frederick B. Merk


Publisher
John Wiley and Sons
Year
1996
Tongue
English
Weight
788 KB
Volume
29
Category
Article
ISSN
0270-4137

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


In situ hybridization studies of α2-macr
✍ McGarvey, T.; Hussain, M. M.; Stearns, M. E. 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 593 KB

We have utilized in situ hybridization and immunocytochemistry techniques to examine the expression of both a,-macroglobulin (a,-MR) and the 39 kDa receptorassociated protein (RAP) in 8 benign (BPH) and 34 malignant human prostate tissues, including 4 metastases. The levels of a,-MR mRNA expression

The role of androgen in determining diff
✍ R. Heer; C.N. Robson; B.K. Shenton; H.Y. Leung 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 234 KB 👁 2 views

## Abstract Abnormal differentiation in epithelial stem cells or their immediate proliferative progeny, the transiently amplifying population (TAP), may explain malignant pathogenesis in the human prostate. These models are of particular importance as differing sensitivities to androgen among epith

The role of androgen in determining diff
✍ R. Heer; C.N. Robson; B.K. Shenton; H.Y. Leung 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 144 KB 👁 1 views

## Abstract The original article to which this erratum refers was published in J Cell Phys (2007) 212:572–578. J. Cell. Physiol. 215: 283–284, 2008. © 2007 Wiley‐Liss, Inc.

55 kDa nuclear matrix protein (nmt55) mR
✍ Hitoshi Ishiguro; Hiroji Uemura; Kiyoshi Fujinami; Naoya Ikeda; Shinsuke Ohta; Y 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 139 KB 👁 3 views

## Abstract Most prostate cancer grows in a hormone‐dependent manner. Most patients, however, show hormone‐independent growth after several years of hormone therapy. The mechanism of hormone‐refractory prostate cancer remains unknown. It is important, therefore, to identify gene(s) related to prost